Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4429-4446

  Hitchcock, Jessica R ^a   Cook, Charlotte N ^a   Bobat, Saeeda ^a   Ross, Ewan A ^a   Flores Langarica, Adriana ^a   Lowe, Kate L ^a   Khan, Mahmood ^a   Coral Dominguez Medina, C ^a   Lax, Sian ^a   Carvalho Gaspar, Manuela ^a   Hubscher, Stefan ^a   Ed Rainger, G ^a   Cobbold, Mark ^a   Buckley, Christopher D ^a   Mitchell, Tim J ^a   Mitchell, Andrea ^a   Jones, Nick D ^a   Van Rooijen, N ^b   Kirchhofer, Daniel ^c   Henderson, Ian R ^a   Adams, David H ^a   Watson, Steve P ^a   Cunningham, Adam F ^a   more..

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C TYPE LECTIN LIKE RECPETOR 2; CLOPIDOGREL; GLYCOPROTEIN P 15095; GLYCOPROTEIN VI; HEPARIN; LECTIN RECEPTOR; PODOPLANIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; CLEC-2 PROTEIN, MOUSE; FIBRINOGEN RECEPTOR; GAMMA INTERFERON; LECTIN; PLATELET MEMBRANE GLYCOPROTEIN VI; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL LOAD; CD3+ T LYMPHOCYTE; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; KUPFFER CELL; LIVER CIRCULATION; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCYTE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SALMONELLOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; COMPLICATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; INTERFERON-GAMMA; KUPFFER CELLS; LECTINS, C-TYPE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PLATELET MEMBRANE GLYCOPROTEINS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; THROMBOSIS; TOLL-LIKE RECEPTOR 4;

EID: 84948843996     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI79070     Document Type: Article

References (78)

1. Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol. 2004;2(9):747-765.
2. Richter-Dahlfors A, Buchan AM, Finlay BB. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med. 1997;186(4):569-580.
3. Butler T, Bell WR, Levin J, Linh NN, Arnold K. Typhoid fever. Arch Intern Med. 1978;138(3):407-410.
4. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ. Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970;283(14):739-746.
5. Jones BD, Falkow S. Salmonellosis: host immune responses and bacterial virulence determinants. Annu Rev Immunol. 1996;14:533-561.
6. Huckstep RL. Typhoid Fever And Other Salmonella Infections. London, United Kingdom: Livingstone; 1962.
7. Wright AE, Knapp HH. A note on the causation and treatment of thrombosis occurring in connection with typhoid fever. Med Chir Trans. 1903;86:1-19.
8. Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad MA. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis. 1985;7(2):244-256.
9. Brown DE, McCoy MW, Pilonieta MC, Nix RN, Detweiler CS. Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis. PLoS One. 2010;5(2):e9441.
10. Vidal S, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med. 1995;182(3):655-666.
11. Bohme DH, Schneider HA, Lee JM. Some phys-iopathological parameters of natural resistance to infection in murine salmonellosis. J Exp Med. 1959;110(1):9-26.
12. Cunningham AF, et al. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol. 2007;178(10):6200-6207.
13. Mastroeni P, Skepper JN, Hormaeche CE. Effect of anti-tumor necrosis factor α antibodies on histopathology of primary Salmonella infections. Infect Immun. 1995;63(9):3674-3682.
14. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34-45.
15. Sun H, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science. 2004;305(5688):1283-1286.
16. Massberg S, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16(8):887-896.
17. Clark SR, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007;13(4):463-469.
18. Cheng AG, McAdow M, Kim HK, Bae T, Mis-siakas DM, Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 2010;6(8):e1001036.
19. Arman M, et al. Amplification of bacteria-induced platelet activation is triggered by FcyRIIA, integrin aIIbp3, and platelet factor 4. Blood. 2014;123(20):3166-3174.
20. Tilley DO, et al. Glycoprotein Iba and FcyRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost. 2013;11(5):941-950.
21. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost. 2011;9(6):1097-1107.
22. Suzuki-Inoue K, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107(2):542-549.
23. Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283.
24. Hou TZ, et al. A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis. FEBS Lett. 2010;584(18):3955-3961.
25. Jackson A, Nanton MR, O'Donnell H, Akue AD, McSorley SJ. Innate immune activation during Salmonella infection initiates extramedullary erythropoiesis and splenomegaly. J Immunol. 2010;185(10):6198-6204.
26. Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor y-chain. FEBS Lett. 1997;413(2):255-259.
27. Talbot S, et al. Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance. Immunology. 2009;128(4):472-483.
28. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology. 2006;130(6):1886-1900.
29. Bao S, Beagley KW, France MP, Shen J, Husband AJ. Interferon-y plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology. 2000;99(3):464-472.
30. Suzuki-Inoue K, et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. 2007;282(36):25993-26001.
31. Christou CM, et al. Renal cells activate the platelet receptor CLEC-2 through podoplanin. Biochem J. 2008;411(1):133-140.
32. Acton SE, et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity. 2012;37(2):276-289.
33. Boulaftali Y, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013;123(2):908-916.
34. Benezech C, et al. CLEC-2 is required for development and maintenance of lymph nodes. Blood. 2014;123(20):3200-3207.
35. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13(2):85-94.
36. VanCott JL, et al. Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med. 1998;4(11):1247-1252.
37. Vazquez-Torres A, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol. 2004;172(10):6202-6208.
38. Changming W, et al. Monocytes can be induced to express lymphatic phenotypes. Lymphology. 2011;44(2):48-53.
39. Lax S, et al. CD248/Endosialin is dynamically expressed on a subset of stromal cells during lym-phoid tissue development, splenic remodeling and repair. FEBS Lett. 2007;581(18):3550-3556.
40. Zarychanski R, et al. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015;43(3):511-518.
41. Finney BA, et al. CLEC-2 and Syk in the mega-karyocytic/platelet lineage are essential for development. Blood. 2012;119(7):1747-1756.
42. Hughes CE, Navarro-Nunez L, Finney BA, Mourao-Sa D, Pollitt AY, Watson SP. CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost. 2010;8(10):2328-2332.
43. Suzuki-Inoue K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem. 2010;285(32):24494-24507.
44. Bender M, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vas c Biol. 2013;33(5):926-934.
45. Waddington CS, et al. An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution. Clin Infect Dis. 2014;58(9):1230-1240.
46. Gordon MA, et al. Invasive non-typhoid salmonel-lae establish systemic intracellular infection in HIV-infected adults: an emerging disease patho-genesis. Clin Infect Dis. 2010;50(7):953-962.
47. Canvin JR, et al. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneu-mococcus. J Infect Dis. 1995;172(1):119-123.
48. Sutton AC, Sevier CE. A study of the bacteriae-mia in lobar pneumonia. Bull Johns Hopkins Hosp. 1917;28:315-318.
49. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(suppl 1):S13-S33.
50. Azad AK, Islam R, Salam MA, Alam AN, Islam M, Butler T. Comparison of clinical features and pathologic findings in fatal cases of typhoid fever during the initial and later stages of the disease. Am J Trop Med Hyg. 1997;56(5):490-493.
51. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore). 1987;66(5):349-388.
52. Govoni G, Gros P. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm Res. 1998;47(7):277-284.
53. Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Re v Nephrol. 2012;8(11):622-633.
54. Ross EA, et al. Resolving Salmonella infection reveals dynamic and persisting changes in murine bone marrow progenitor cell phenotype and function. Eur J Immunol. 2014;44(8):2318-2330.
55. Seebaran AR, Coovadia YM, Bhana RH, Rajput MC, Naidoo BT, Haffejee IE. Typhoid fever in the adult and paediatric Indian population of Durban. S Afr Med J. 1990;77(1):14-17.
56. Toso JF, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20(1):142-152.
57. Jayachandran M, Miller VM, Brunn GJ, Owen WG. Platelet response as a sentinel marker of toll-like receptor 4 activation in mice. Thromb Res. 2010;126(5):414-417.
58. Gondwe EN, et al. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA. 2010;107(7):3070-3075.
59. Graham SM, Molyneux EM, Walsh AL, Chees-brough JS, Molyneux ME, Hart CA. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J. 2000;19(12):1189-1196.
60. MacLennan CA, et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest. 2008;118(4):1553-1562.
61. Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013;161(5):609-622.
62. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259(5102):1739-1742.
63. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68(5):869-877.
64. Reinhardt RL, Liang HE, Locksley RM. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol. 2009;10(4):385-393.
65. Stadtfeld M, Graf T. Assessing the role of hemato-poietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development. 2005;132(1):203-213.
66. Kato K, et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood. 2003;102(5):1701-1707.
67. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 1997;6(4):469-477.
68. Cunningham AF, et al. Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. Eur J Immunol. 2004;34(11):2986-2995.
69. Buiting AM, Van Rooijen N. Liposome mediated depletion of macrophages: an approach for fundamental studies. J Drug Target. 1994;2(5):357-362.
70. Van Rooijen N. The liposome-mediated macro-phage 'suicide' technique. J Immunol Methods. 1989;124(1):1-6.
71. Van Rooijen N, Sanders A. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology. 1996;23(5):1239-1243.
72. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol. 2013;14(8):785-792.
73. + regulatory T cell and IgA responses in the mesenteric lymph node. J Immunol. 2012;189(12):5745-5754.
74. Weiler-Guettler H, et al. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest. 1998;101(9):1983-1991.
75. Kirchhofer D, Moran P, Bullens S, Peale F, Bunting S. A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost. 2005;3(5):1098-1099.
76. Klein I, et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood. 2007;110(12):4077-4085.
77. Li PZ, Li JZ, Li M, Gong JP, He K. An efficient method to isolate and culture mouse Kupffer cells. Immunol Lett. 2013;158(1-2):52-56.
78. Sakai A, Tanaka S, Kountz SL. Liver and immune responses. Transplantation. 1978;25(3):110-114.